MMEN.CN MedMen Enterprises Inc. CNQ +33.33% on 24 Feb 2026: key outlook and target
MMEN.CN stock rallied 33.33% to C$0.02 on 24 Feb 2026 during market hours on the CNQ, making MedMen Enterprises Inc. a top gainer in Canada today. Trading volume hit 189,038.00 shares, above the 50-day average of 145,639.00, suggesting short-term buyer interest. The jump follows small-cap volatility after markets opened at C$0.015 and a day high of C$0.02. Investors should weigh weak fundamentals — EPS of -0.15 and negative PE — against upside from a low base and recent operational updates.
Price action and intraday drivers for MMEN.CN stock
MedMen Enterprises Inc. (MMEN.CN) traded between a day low of C$0.015 and a day high of C$0.02 on 24 Feb 2026. Volume of 189,038.00 exceeded average volume of 145,639.00, giving the move liquidity. One immediate driver is speculative buying around micro-cap cannabis names; another is technical support near the year low C$0.015. The 50-day average is C$0.0231 and the 200-day average is C$0.02665, both above the current price, signaling a recovering but still depressed trend.
Fundamentals and valuation snapshot for MMEN.CN stock
MedMen reports an EPS of -0.15 and a trailing negative PE of -0.13, reflecting consistent losses. Market capitalization stands at C$27,664,000.00 with 1,383,200,000.00 shares outstanding. Price-to-sales is 0.14 and price-to-book is 0.11, indicating a heavy discount to book value metrics. Liquidity ratios are weak: current ratio 0.49 and cash per share C$0.01, while debt-to-equity is 2.61, highlighting balance-sheet pressure.
Sector backdrop and what it means for MMEN.CN stock
MMEN.CN sits in the Healthcare sector under Drug Manufacturers – Specialty & Generic. The Canadian healthcare group shows a mixed 1-year performance, and sector pressure has weighed on cannabis-related retailers. Relative to sector averages — current ratio near 2.45 and avg debt-to-equity around -0.88 for healthcare peers — MedMen displays weaker liquidity and higher leverage. That gap amplifies risk if revenue recovery stalls.
Technical and trading context for MMEN.CN stock
Short-term technicals favor buyers at the intraday level: price rebounded off the year low C$0.015 and outpaced average volume today. RelVolume is 1.30, showing above-normal activity. Key resistance sits at the 50-day MA C$0.0231 and then near the 200-day MA C$0.02665. A sustained move above C$0.03 would reduce immediate downtrend risk. Watch volatility: 1-year change is -55.56%, and long-term holders face significant drawdown.
Meyka AI grade and analyst view on MMEN.CN stock
Meyka AI rates MMEN.CN with a score out of 100: 60.43 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score highlights modest recovery signs but material balance-sheet and profitability risks. Meyka AI, our AI-powered market analysis platform, flags event-driven trading as the main near-term catalyst rather than fundamental recovery.
Final Thoughts
Key takeaways for MMEN.CN stock: today’s intraday gain to C$0.02 on 24 Feb 2026 came with volume 189,038.00, marking it a top gainer on CNQ but not yet a turn in fundamentals. The company shows negative EPS -0.15, high leverage with debt-to-equity 2.61, and weak liquidity with current ratio 0.49. From a trading standpoint, short-term upside targets are the 50-day MA C$0.0231 and the 200-day MA C$0.02665. Meyka AI’s forecast model projects a 12-month base case target of C$0.04 (implied upside 100.00% from C$0.02) and a bull case of C$0.06 (implied upside 200.00%) if operational metrics improve and sector sentiment shifts. These model projections are estimates only; they are model-based projections and not guarantees. Investors should weigh event-driven momentum against fragile fundamentals and consider position sizing accordingly. For quick reference and ongoing updates, see the company site and data profile: MedMen Corporate and MMEN.CN profile at FinancialModelingPrep. For Meyka AI market tools and real-time alerts visit our internal page: https://meyka.ai/stocks/MMEN.CN
FAQs
Why did MMEN.CN stock jump today?
MMEN.CN stock rose 33.33% on 24 Feb 2026 after above-average volume (189,038.00). The move reflects short-term speculative buying and a rebound off the year low C$0.015, not confirmed by improved earnings or cash flow.
What is Meyka AI’s grade for MMEN.CN stock and what does it mean?
Meyka AI rates MMEN.CN 60.43 (Grade B, HOLD). The grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst views. It signals cautious stance due to weak liquidity and negative EPS.
What are realistic price targets for MMEN.CN stock?
Meyka AI’s model projects a 12-month base case of C$0.04 and a bull case of C$0.06. Base case implies 100.00% upside from C$0.02. Forecasts are model-based projections and not guarantees.
Should investors treat MMEN.CN stock as a long-term buy?
Given negative EPS -0.15, high debt-to-equity 2.61, and low current ratio 0.49, MMEN.CN is risky for long-term portfolios. Consider trades sized for high volatility and monitor earnings updates and cash metrics.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.